WallStSmart
TELA

Tela Bio Inc

NASDAQ: TELA · HEALTHCARE · MEDICAL DEVICES

$0.87
+1.72% today

Updated 2026-04-30

Market cap
$34.90M
P/E ratio
P/S ratio
0.44x
EPS (TTM)
$-0.83
Dividend yield
52W range
$1 – $2
Volume
0.2M

Tela Bio Inc (TELA) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
-14.6%
Last 4 quarters
Revenue YoY growth
+18.2%
Most recent quarter
EPS YoY growth
+26.1%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-2.1%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-12.3%
2025-11-13
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-19$-0.17+2.9%$0.72$0.78+8.1%
2025-11-13$-0.19-18.8%$1.14$1.00-12.3%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.18$-0.17+2.9%$20.87M+18.2%
2025-09-30$-0.16$-0.19-18.8%$20.69M+9.1%
2025-06-30$-0.18$-0.22-22.2%$20.20M+25.5%
2025-03-31$-0.21$-0.25-20.5%$18.52M+11.5%
2024-12-31$-0.22$-0.23-3.6%$17.65M+3.8%
2024-09-30$-0.40$-0.42-5.0%$18.96M+25.9%
2024-06-30$-0.47$-0.51-8.5%$16.09M+11.0%
2024-03-31$-0.50$-0.23+54.0%$16.60M+39.4%
2023-12-31$-0.43$-0.53-23.3%$17.00M
2023-09-30$-0.49$-0.45+8.2%$15.05M
2023-06-30$-0.53$-0.46+13.2%$14.49M
2023-03-31$-0.56$-0.63-12.5%$11.91M

Frequently asked questions

Has Tela Bio Inc beaten earnings estimates?
Tela Bio Inc has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of -14.6% over the last 4 quarters.
How does TELA stock react to earnings?
TELA stock has moved an average of -2.1% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Tela Bio Inc's revenue growth rate?
Tela Bio Inc reported year-over-year revenue growth of +18.2% in its most recent quarter, with EPS growing +26.1% year-over-year.